FLAMMA NEWSLETTER: OCTOBER 2021
The latest from Flamma
Turning the corner in 2021- CPhI in Milan Nov. 9-11:

Hello Kenneth:

We think it is safe to say that since the start of 2020, the world has been turned upside down and shaken a few times. At Flamma, we are grateful to continue to work hard in order to help provide needed materials for the pharmaceutical industry. Adjustments have been made and our team has responded to the challenges set forth.

As noted above, Flamma will be at CPhI Worldwide in Milan from November 9-11. If you are attending, please feel free to let us know directly or visit our website to schedule a meeting. We know this will NOT be a typical CPhI but we are looking forward to seeing customers and enjoying some face to face time once again. For those traveling, be safe and we hope to see you soon. If you are not attending, we hope to see you at the next CPhI Worldwide in Hall 8 in Frankfurt in November 1-3, 2022!
Quick Site Updates
Flamma USA enters the Highly Potent Market
Flamma USA
The HPAPI Suite at Flamma USA has been re-commissioned and is ready to serve customers who need to work on potent materials. The suite offers customers the ability to do early stage API work quickly.

Flamma USA now has 35 employees and is looking forward to helping companies not only in the USA but elsewhere in the world with their pre-clinical needs (GLP tox material) as well as following up with GMP material. We offer another choice in the industry and the Philly area is a short trip for many customers!
Flamma Honkai Inspected by Chinese FDA
Flamma Honkai has passed its final inspection by the Chinese National Medical Products Administration (NMPA) formally known as the Chinese FDA (China's regulatory agency).
 
This milestone marks Flamma’s ongoing efforts to continue to bring significant value and trust from its customer base. 
R&D Admin. building
Flamma Honkai can help companies looking to manufacture APIs within China for the Chinese marketplace. Companies can also take advantage of our Italian sites for APIs as well. This is another example of what makes Flamma unique within the industry.
Flamma Italy nears completion of New R&D Building
R&D Building as of Oct. 2021

Construction of the new state of the art R&D building is nearing completion. We will begin transitioning from the current R&D building into our new R&D building in Q2/2022 and be fully moved in by early Q3/2022.

As mentioned, this will quadruple our R&D space and allow for the Analytical Team to expand into the previously shared building. This is an exciting time for the site and will increase our efficiency for customers.
Flamma in the news
Talking with Flamma......
Flamma was fortunate to share insights on a Live CPhI North America panel discussion entitled: “The Real Cost of Bringing Manufacturing Home”. The panel discussion is available on demand. If interested, please go to https://player.vimeo.com/video/583415271

Also, Flamma was mentioned in the following articles:

Flamma was spotlighted in Chimica Oggi-Chemistry Today. The article is entitled “A Word With Flamma” can be found here.

"How the drug services industry found itself prepared for a pandemic" was in Chemical & Engineering News recently. Click here to go to the article
Upcoming Flamma Events
ONLINE:
Flamma Fridays- Every 4th Friday of every other month (learn more at FlammaFridays.com)

CONFERENCES:
CPhI Worldwide 2021- Milan, Italy from November 9-11, 2021
DCAT 2022- New York City, NY from March 20-24, 2022
CPhI North America 2022- Philadelphia from May 5-7, 2022

If possible, we hope to see you in person! Stay up to date at https://www.flammagroup.com/events/
Flamma respects your privacy and will never sell your information.
You will NEVER receive more than 4 newsletters per year. Thank you for your support.